Record Quarterly Revenue
Product revenues reached a quarterly record of $394 million, up 11.3% year-over-year (7.2% growth excluding foreign currency translation).
Strong Automotive Segment Performance
Automotive Climate & Comfort Solutions revenue grew 13.6% YoY (9.8% ex-FX). Lumbar and massage comfort solutions grew 33% YoY, driven by program ramps and increased take rates in China.
Improved Profitability
Adjusted EBITDA was $49.3 million, representing 12.5% of sales versus 11.1% in prior-year Q1 (an increase of 140 basis points). Adjusted diluted EPS was $0.84, up 65% from $0.51 a year ago.
Significant New Business Wins
Secured $395 million of automotive new business awards, described as well balanced across region, customer and product; pursuit pipeline described as robust for the remainder of the year.
Expansion Beyond Automotive
Entered home and office market with KUKA Home production launches and additional win with a leading North American furniture brand (fourth consecutive quarter with a new home/office customer). Management estimates furniture opportunity could clip $50–$100 million by 2028 and add 1–2 points of growth.
Medical Product Progress
Submitted FDA 510(k) for ThermAffyx patient warming/securement system; regulatory approval process remains on track and revenue is expected to begin later this year.
Strategic M&A to Accelerate Growth
Announced planned combination with Modine Performance Technologies to expand product portfolio and end-market exposure; combined 5-year target of $3.5 billion revenue and more than $0.5 billion of earnings.
Balance Sheet and Cash Generation Improvements
Net leverage ended Q1 at 0.2 turns, liquidity of $456 million, an $8 million year-over-year improvement in operational cash flow, and CapEx purchases of $5.6 million (down $9.2 million YoY).
Operational and Organizational Progress
Implemented organizational realignment and operating system improvements; expected OpEx annual run-rate benefit ~ $10 million with about half (~$5 million) hitting this year, driving improved execution and margin expansion.
Maintained Full-Year Guidance
Maintained 2026 revenue guidance of $1.5–$1.6 billion (~3% growth vs market -2%) and adjusted EBITDA guidance of $175–$195 million (implied ~12% margin midpoint) despite macro uncertainty.